| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.7B | $0.4B | $0.4B | $0.4B | $0.4B | $0.3B | $0.2B | $0.2B |
| EPS (Basic) | $9.35 | $9.05 | $7.22 | $8.93 | $7.31 | $5.95 | $4.99 | $3.97 |
| EPS (Diluted) | $9.29 | $8.99 | $7.18 | $8.86 | $7.24 | $5.93 | $4.96 | $3.93 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $73.1B | $50.4B | $44.0B | $38.5B | $42.7B | $33.1B | $26.6B | $23.4B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $7.8B | $8.4B | $5.5B | $1.6B | $9.2B | $3.5B | $1.7B | $1.7B |
| Total Liabilities | $65.4B | $46.9B | $40.9B | $35.8B | $39.5B | $30.1B | $24.0B | $21.1B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $7.7B | $3.5B | $3.1B | $2.7B | $3.1B | $3.0B | $2.6B | $2.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.0B | $0.2B | $0.5B | $0.8B | $0.5B | $0.4B | $0.3B | $0.3B |
| Investing Cash Flow | $-5.6B | $-3.3B | $-1.3B | $-3.8B | $-4.2B | $-4.5B | $-3.0B | $-1.8B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.1B | $0.0B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $3.9B | $6.0B | $4.8B | $-4.6B | $9.4B | $5.9B | $2.7B | $1.4B |